European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360–5 - Reply | Haematologica

Thomas Buhr; Konnie Hebeda; Vassiliki Kaloutsi; Anna Porwit; Jon Van der Walt; Hans Kreipe

首页> 外文期刊>Haematologica >European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360–5 - Reply | Haematologica

【24h】

European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360–5 - Reply | Haematologica

机译：欧洲骨髓工作组对世界卫生组织标准的可重复性进行的试验，以区分原发性血小板增多症与原发性原发性骨髓纤维化。 Haematologica 2012; 97（3）：360–5-回复|血液学

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Haematologica》 |2012年第3期|共2页
作者
Thomas Buhr; Konnie Hebeda; Vassiliki Kaloutsi; Anna Porwit; Jon Van der Walt; Hans Kreipe;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类血液及淋巴系疾病;
关键词

相似文献

外文文献

1. European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360–5 - Comment | Haematologica [J] . Jürgen Thiele, Attilio Orazi, Hans Michael Kvasnicka, Haematologica . 2012,第3期

机译：欧洲骨髓工作组对世界卫生组织标准的可重复性进行的试验，以区分原发性血小板增多症与原发性原发性骨髓纤维化。 Haematologica 2012; 97（3）：360–5-评论|血液学
2. Practical application and clinical impact of the WHO histopathological criteria on bone marrow biopsy for the diagnosis of essential thrombocythemia versus prefibrotic primary myelofibrosis. [J] . Brousseau M, Parot Schinkel E, Moles MP, Histopathology: Official Journal of the British Division of the International Academy of Pathology . 2010,第6期

机译：WHO组织病理学标准在骨髓活检中的实际应用和临床影响，用于诊断原发性血小板增多症与纤维化前原发性骨髓纤维化。
3. Mini-dose of thalidomide for treatment of primary myelofibrosis. Report of a case with complete reversal of bone marrow fibrosis and splenomegaly | Haematologica [J] . A. Berrebi, E. Feldberg, I. Spivak, Haematologica . 2007,第2期

机译：沙利度胺小剂量治疗原发性骨髓纤维化。一例完全逆转骨髓纤维化和脾肿大的报告血液学
4. European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360–5 - Reply [O] . Thomas Buhr, Konnie Hebeda, Vassiliki Kaloutsi, 2012

机译：欧洲骨髓工作组对世界卫生组织标准的可重复性进行的试验以区分原发性血小板增多症与原发性原发性骨髓纤维化。血液学2012; 97（3）：360-5-回复
5. European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360-5-Reply [O] . Buhr, Thomas, Hebeda, Konnie, Kaloutsi, Vassiliki, 2012

机译：欧洲骨髓工作组对世界卫生组织标准的可重复性进行的试验，以区分原发性血小板增多症与原发性原发性骨髓纤维化。 Haematologica 2012; 97（3）：360-5-回复

European Bone Marrow Working Group trial on reproducibility of World Health Organization criteria to discriminate essential thrombocythemia from prefibrotic primary myelofibrosis. Haematologica 2012;97(3):360–5 - Reply | Haematologica

著录项

相似文献

相关主题

期刊订阅